SCHEMBL1694293

SCHEMBL1694293

NNc1nc2c(s1)COc1cc(Cl)c(Cl)cc1-2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4E P06730 3/20 0.46
LMNA P02545 8/20 0.42
HTT P42858 4/20 0.42
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 7/20 0.40
GAA P10253 6/20 0.40
MEN1 O00255 8/20 0.39
KMT2A Q03164 8/20 0.39
MAPT P10636 8/20 0.39
POLB P06746 2/20 0.39
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
NPY5R Q15761 3/20 0.35
HPGD P15428 2/20 0.34
TDP1 Q9NUW8 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1694677 0.74 EIF4E (0.44) EIF4ELMNAKDM4EALDH1A1MEN1
SCHEMBL988703 0.66 PIK3CA (0.44) GAAMEN1KMT2AMAPTNPC1
SCHEMBL30953684 0.65 KDM4E (0.65) LMNAHTTKDM4EALDH1A1GAA
SCHEMBL10120330 0.64 EIF4E (0.46) EIF4ELMNAHTTKDM4EALDH1A1
SCHEMBL9205554 0.60 ALDH1A1 (0.69) LMNAHTTKDM4EALDH1A1GAA
SCHEMBL30953618 0.59 KDM4E (0.65) LMNAHTTKDM4EALDH1A1GAA
SCHEMBL30953763 0.59 KDM4E (0.65) LMNAKDM4EALDH1A1GAAMAPT
SCHEMBL30953632 0.59 KDM4E (0.65) LMNAKDM4EALDH1A1GAAMAPT
SCHEMBL16357239 0.59 MAPT (0.42) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL1694929 0.58 MAPT (0.46) LMNAHTTKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969573-B2 Compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-03-03 US disclosed
US-8969573-B2 Compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-03-03 US disclosed
US-8969573-B2 Compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-03-03 US disclosed
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-07-11 US disclosed
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-07-11 US disclosed
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-07-11 US disclosed
EP-2585453-A2 COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION President and Fellows of Harvard College (US) 2013-05-01 EP disclosed
WO-2012006068-A2 COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-01-12 WO disclosed
WO-2012006068-A2 COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation MKI67, EIF2AK2, CDK2 EIF4E 39/4885LMNA 1228/4885HTT 1165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.